These strategic partnerships have consistently delivered innovative healthcare solutions that improve access to care.

We collaborate with health systems to connect patients with breakthrough advanced therapies, including 26 FDA approved cell and gene therapy products and over 2,500 therapies currently in development, spanning over 150 medical conditions.

Through these partnerships, we've demonstrated consistent success in overcoming complex operational, financial, and clinical barriers to advanced care delivery.

Led by founder Jack Shields Sr. and a seasoned executive team, Shields Advanced Therapies continues to deliver pioneering solutions through its expansive healthcare network.